LEGN logo

Legend Biotech (LEGN) Net Income

Annual Net Income

-$518.25 M
-$71.91 M-16.11%

31 December 2023

LEGN Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Net Income

-$125.32 M
-$107.13 M-588.73%

30 September 2024

LEGN Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Net Income

-$348.13 M
-$63.11 M-22.14%

30 September 2024

LEGN TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LEGN Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-16.1%-101.5%+31.6%
3 y3 years-94.6%+0.1%-6.1%
5 y5 years-10000.0%-350.8%-404.3%

LEGN Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-94.6%at low-588.7%+37.1%-22.1%+34.6%
5 y5 years<-9999.0%at low-588.7%+37.1%-404.3%+34.6%
alltimeall time<-9999.0%at low-908.2%+37.1%-2700.7%+34.6%

Legend Biotech Net Income History

DateAnnualQuarterlyTTM
Sept 2024
-
-$125.32 M(+588.7%)
-$348.13 M(+22.1%)
June 2024
-
-$18.20 M(-69.6%)
-$285.01 M(-38.8%)
Mar 2024
-
-$59.79 M(-58.7%)
-$465.95 M(-10.1%)
Dec 2023
-$518.25 M(+16.1%)
-$144.82 M(+132.8%)
-$518.25 M(+1.8%)
Sept 2023
-
-$62.21 M(-68.8%)
-$509.31 M(-4.3%)
June 2023
-
-$199.13 M(+77.6%)
-$532.06 M(+1.1%)
Mar 2023
-
-$112.10 M(-17.5%)
-$526.16 M(+17.9%)
Dec 2022
-$446.35 M(+10.6%)
-$135.88 M(+59.9%)
-$446.35 M(+7.2%)
Sept 2022
-
-$84.96 M(-56.0%)
-$416.18 M(-8.9%)
June 2022
-
-$193.23 M(+498.4%)
-$456.62 M(+28.6%)
Mar 2022
-
-$32.29 M(-69.5%)
-$354.97 M(-14.1%)
Dec 2021
-$403.58 M
-$105.71 M(-15.7%)
-$413.20 M(+25.9%)
DateAnnualQuarterlyTTM
Sept 2021
-
-$125.39 M(+36.9%)
-$328.22 M(+21.8%)
June 2021
-
-$91.58 M(+1.2%)
-$269.37 M(-13.8%)
Mar 2021
-
-$90.52 M(+336.8%)
-$312.67 M(+17.4%)
Dec 2020
-$266.37 M(+100.3%)
-$20.72 M(-68.9%)
-$266.37 M(-14.0%)
Sept 2020
-
-$66.55 M(-50.7%)
-$309.59 M(+14.3%)
June 2020
-
-$134.88 M(+205.0%)
-$270.84 M(+64.4%)
Mar 2020
-
-$44.23 M(-30.8%)
-$164.77 M(+23.9%)
Dec 2019
-$132.97 M(+4676.3%)
-$63.94 M(+130.0%)
-$132.97 M(+92.6%)
Sept 2019
-
-$27.80 M(-3.5%)
-$69.03 M(+67.4%)
June 2019
-
-$28.80 M(+131.7%)
-$41.23 M(+231.7%)
Mar 2019
-
-$12.43 M
-$12.43 M
Dec 2018
-$2.78 M
-
-

FAQ

  • What is Legend Biotech annual net profit?
  • What is the all time high annual net income for Legend Biotech?
  • What is Legend Biotech annual net income year-on-year change?
  • What is Legend Biotech quarterly net profit?
  • What is the all time high quarterly net income for Legend Biotech?
  • What is Legend Biotech quarterly net income year-on-year change?
  • What is Legend Biotech TTM net profit?
  • What is the all time high TTM net income for Legend Biotech?
  • What is Legend Biotech TTM net income year-on-year change?

What is Legend Biotech annual net profit?

The current annual net income of LEGN is -$518.25 M

What is the all time high annual net income for Legend Biotech?

Legend Biotech all-time high annual net profit is -$2.78 M

What is Legend Biotech annual net income year-on-year change?

Over the past year, LEGN annual net profit has changed by -$71.91 M (-16.11%)

What is Legend Biotech quarterly net profit?

The current quarterly net income of LEGN is -$125.32 M

What is the all time high quarterly net income for Legend Biotech?

Legend Biotech all-time high quarterly net profit is -$12.43 M

What is Legend Biotech quarterly net income year-on-year change?

Over the past year, LEGN quarterly net profit has changed by -$63.11 M (-101.46%)

What is Legend Biotech TTM net profit?

The current TTM net income of LEGN is -$348.13 M

What is the all time high TTM net income for Legend Biotech?

Legend Biotech all-time high TTM net profit is -$12.43 M

What is Legend Biotech TTM net income year-on-year change?

Over the past year, LEGN TTM net profit has changed by +$161.18 M (+31.65%)